Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vivos Inc (RDGL)

Vivos Inc (RDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 32,736
  • Shares Outstanding, K 454,665
  • Annual Sales, $ 30 K
  • Annual Income, $ -2,910 K
  • EBIT $ -3 M
  • EBITDA $ -3 M
  • 60-Month Beta -0.39
  • Price/Sales 545.60
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $0.00 on 11/12/25
  • Next Earnings Date 03/23/26
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Finance
  • INDUSTRY GROUPING Finance - SBIC & Commercial

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0481 +49.06%
on 11/19/25
0.0810 -11.48%
on 11/17/25
-0.0063 (-8.08%)
since 11/14/25
3-Month
0.0481 +49.06%
on 11/19/25
0.0997 -28.08%
on 09/17/25
-0.0208 (-22.49%)
since 09/15/25
52-Week
0.0425 +68.71%
on 08/14/25
0.1739 -58.77%
on 02/19/25
-0.0089 (-11.04%)
since 12/13/24

Most Recent Stories

More News
Vivos Inc. Issues Shareholder Update Letter

Kennewick, WA, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) – The Company continues to prioritize securing FDA Investigational Device Exemption (IDE) approval to initiate human clinical...

RDGL : 0.0717 (-0.42%)
Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics

Kennewick, WA, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) today announced enhanced cooperation with Exubrion Therapeutics to advance the use of targeted radioactive isotope technology...

RDGL : 0.0717 (-0.42%)
Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel®

Richland, WA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) announced today that they have appointed Dr. John J. Smith, M.D., J.D., and his team at Hogan Lovells as the company’s lead...

RDGL : 0.0717 (-0.42%)
Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India

Kennewick, WA, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The Vivos Board granted authorization to form a wholly owned corporate subsidiary in India. Vivos Inc filed for the name...

RDGL : 0.0717 (-0.42%)
Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India

Kennewick, WA, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The Vivos Board granted authorization to form a wholly owned corporate subsidiary in India. Vivos Inc filed for the name...

RDGL : 0.0717 (-0.42%)
Vivos Inc. Demonstrates Precision in Precision Radionuclide Therapy

Kennewick, WA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) announced new data demonstrating the exceptional precision of its proprietary Precision Radionuclide Therapy (RadioGel ® for...

RDGL : 0.0717 (-0.42%)
Vivos Inc Files Critical Patent For Hydrogel Electron Beam Sterilization

Kennewick, WA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) Vivos Inc filed a provisional patent No.: 63/873,014 - STERILE THERMOGELS Vivos Inc. is pleased to announce the successful...

RDGL : 0.0717 (-0.42%)
Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Declined By FDA

Kennewick, WA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) Following the 30-day review period, the FDA declined approval of the Radiogel ® IDE submission. We are now focused on addressing...

RDGL : 0.0717 (-0.42%)
Vivos Inc. Submitted the Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Clinic

Kennewick, WA, July 14, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a pioneer in Precision Radionuclide TherapyTM (PRnT) solutions, today announced the submission of its Investigational Device Exemption...

RDGL : 0.0717 (-0.42%)
Vivos Inc. Certifies University of Florida Veterinary Hospital for IsoPet® Precision Radionuclide Therapy™

RDGL : 0.0717 (-0.42%)

Business Summary

Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington.

See More

Key Turning Points

3rd Resistance Point 0.0757
2nd Resistance Point 0.0740
1st Resistance Point 0.0728
Last Price 0.0717
1st Support Level 0.0699
2nd Support Level 0.0682
3rd Support Level 0.0670

See More

52-Week High 0.1739
Fibonacci 61.8% 0.1237
Fibonacci 50% 0.1082
Fibonacci 38.2% 0.0927
Last Price 0.0717
52-Week Low 0.0425

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar